Executive summary: It's wrong not to test: The case for universal, frequent rapid COVID-19 testing
- PMID: 33644720
- PMCID: PMC7894218
- DOI: 10.1016/j.eclinm.2021.100759
Executive summary: It's wrong not to test: The case for universal, frequent rapid COVID-19 testing
Conflict of interest statement
The authors declare that they do not have any manifest conflict of interest. Dr. Buchan reports personal fees and other from his service as Chief Data Scientist Advisor to AstraZeneca and a grant from the National Institute for Health Research (NIHR), all outside the submitted work. Ms. Aspinall reports that she is compensated for her service on the Boards of Directors of both Orasure and Abcam as well as for serving as an Advisor to Cepheid. Dr. Binding reports that he works for Robert Bosch GmbH. There is a separate division within the company producing and selling rapid PCR tests for SARS-CoV-2 ("Vivalytics"). He declares that he has no work ties with that team.
References
-
- U.S. Food and Drug Administration (FDA). Coronavirus disease 2019 testing basics. https://www.fda.gov/consumers/consumer-updates/coronavirus-disease-2019-.... Accessed January 24, 2021.
-
- Rapid Tests. An appeal for rapid antigen tests for COVID-19. Published 15 December 2020. https://rapidtests.org/expert-letter. Accessed 24 January 2021.
-
- Mina M.J., Andersen K.G. COVID-19 testing: one size does not fit all. Science. 2021;371(6525):126–127. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
